Q & A

CEO shares SAE Renewables’ strategic vision and future plans in Exclusive Interview (LON:SAE)

SAE Renewables (LON:SAE) CEO Graham Reid discusses the company's strategy centered on Uskmouth and Meygen sites, battery energy storage, and future plans in an exclusive DirectorsTalk interview...

EDX Medical CEO Dr Mike Hudson on Board strength, cancer testing and future plans (LON:EDX)

EDX Medical Group plc's CEO, Dr. Mike Hudson, discusses the company's innovative digital diagnostics, their robust Board, and upcoming hereditary cancer testing...

Nuformix Executive Director discusses patent updates, interim results and future plans (LON:NFX)

Nuformix plc (LON:NFX) Executive Director Dr. Dan Gooding reveals insights on new patents for NXP002 & NXP004, interim results, and future plans in an exclusive interview...

Volta Finance’s recent performance and market perspectives (LON:VTA)

Discover insights on Volta Finance plc (LON:VTA) as Hardman & Co’s Analyst Mark Thomas discusses share price discounts, NAV sustainability, and investment risks...

Hercules Site Services discusses Record Growth, Training Academy, and Future Plans (LON:HERC)

Hercules Site Services plc's CEO and CFO discuss record revenues, training academy success, Future Build integration, and future growth opportunities...

Challenger Energy CEO on Charlestown deal, new Board member, and offshore license updates (LON:CEG)

Learn about Challenger Energy Group plc's recent investment by Charlestown Energy and the structure of the deal in this exclusive interview with CEO Eytan Uliel...

Alien Metals’ Technical Director on the Pinderi Hills review and future plans (LON:UFO)

Alien Metals Limited's Non-Executive Technical Director Rob Mosig discusses his appointment, the Pinderi Hills review, and Geoscience Australia's high potential rating...

Baron Oil CEO discusses name change to Sunda Energy and Southeast Asia focus (LON:BOIL)

Baron Oil plc CEO Dr. Andy Butler discusses the proposed name change to Sunda Energy, the Chuditch project, and drilling plans for 2025...

ICG Enterprise Trust’s key insights and strategies (LON:ICGT)

Learn more about ICG Enterprise Trust plc (LON:ICGT) in this exclusive interview with Hardman & Co's Analyst Mark Thomas. Discover key insights on their performance and strategies...

Ilika’s Graeme Purdy on fundraising and key milestones (LON:IKA)

Ilika plc CEO Graeme Purdy discusses proposed placing, trading update, and key milestones in exclusive interview. Details on proceeds and operational highlights...

NB Private Equity Partners 2023 performance and EBITDA margins (LON:NBPE)

Discover why NB Private Equity Partners (LON:NBPE) is making waves in the market with Hardman & Co's exclusive interview with DirectorsTalk...

Duke Capital’s unique hybrid capital solutions for SME growth and investor returns (LON:DUKE)

Learn about Duke Capital plc (LON:DUKE) and its unique hybrid capital solution for SMEs in UK, Europe, and North America in this exclusive interview summary...

itim Group CEO & CFO discuss Financial Success, Strategic Investments, and Future Outlook

Discover how itim Group plc (LON:ITIM) has increased revenues by 15% and EBITDA by 200%. Learn about their resilient business model and future strategies...

Cerillion CEO on Strong Interim Results, Strategic Growth, and Confidence in Future Prospects (LON:CER)

Cerillion plc CEO Louis Hall discusses interim results, product potential, and scaling up for growth in an exclusive interview with DirectorsTalk...

Zotefoams expands horizons with Shincell Global Alliance (LON:ZTF)

Zotefoams plc CFO Gary McGrath discusses the Shincell Global Alliance in an exclusive interview with DirectorsTalk. Find out what investors can expect in the coming months...

One Health Group plc CEO on Progress, Future Outlook, and NHS Contracts (AQSE:OHGR)

One Health Group plc CEO Adam Binns discusses their progress, future outlook, five-year NHS contracts, and the impact of political change in an exclusive interview...

Chesnara Plc results showcase Strong Economic Value Profit and Dividend Uplift (LON:CSN)

Learn about Chesnara plc's 2023 results and operational improvements in this exclusive interview with Hardman & Co's Financial Analyst Dr Brian Moretta...

City of London Investment Group Q3 update, FUM rises 5.5% (LON:CLIG)

City of London Investment Group plc (LON:CLIG) saw a positive quarter with $10.1 billion in Funds under Management. Find out more in this exclusive interview...

Avation’s Executive Chairman on the good working relationship with ATR, adding further growth (LON:AVAP)

Avation plc Executive Chairman Jeff Chatfield discusses AT2 72 engines, SAF certification, and more in an exclusive interview with DirectorsTalk. Learn about the company's growth sources and commitment to low CO2 transition...

Argent BioPharma MD on being a meaningful breakthrough drug discovery company (ASX:RGT)

Roby Zomer, CEO of Argent BioPharma Ltd, discusses the company's restructuring, product portfolio, and outlook in an exclusive interview with DirectorsTalk. Learn more about their focus on drug discovery and biopharma...
Search

Funds

Search Results for: スピードらーに

CEO shares SAE Renewables’ strategic vision and future plans in Exclusive Interview (LON:SAE)

SAE Renewables (LON:SAE) CEO Graham Reid discusses the company's strategy centered on Uskmouth and Meygen sites, battery energy storage, and future plans in an exclusive DirectorsTalk interview...

EDX Medical CEO Dr Mike Hudson on Board strength, cancer testing and future plans (LON:EDX)

EDX Medical Group plc's CEO, Dr. Mike Hudson, discusses the company's innovative digital diagnostics, their robust Board, and upcoming hereditary cancer testing...

Nuformix Executive Director discusses patent updates, interim results and future plans (LON:NFX)

Nuformix plc (LON:NFX) Executive Director Dr. Dan Gooding reveals insights on new patents for NXP002 & NXP004, interim results, and future plans in an exclusive interview...

Volta Finance’s recent performance and market perspectives (LON:VTA)

Discover insights on Volta Finance plc (LON:VTA) as Hardman & Co’s Analyst Mark Thomas discusses share price discounts, NAV sustainability, and investment risks...

Hercules Site Services discusses Record Growth, Training Academy, and Future Plans (LON:HERC)

Hercules Site Services plc's CEO and CFO discuss record revenues, training academy success, Future Build integration, and future growth opportunities...

Challenger Energy CEO on Charlestown deal, new Board member, and offshore license updates (LON:CEG)

Learn about Challenger Energy Group plc's recent investment by Charlestown Energy and the structure of the deal in this exclusive interview with CEO Eytan Uliel...

Alien Metals’ Technical Director on the Pinderi Hills review and future plans (LON:UFO)

Alien Metals Limited's Non-Executive Technical Director Rob Mosig discusses his appointment, the Pinderi Hills review, and Geoscience Australia's high potential rating...

Baron Oil CEO discusses name change to Sunda Energy and Southeast Asia focus (LON:BOIL)

Baron Oil plc CEO Dr. Andy Butler discusses the proposed name change to Sunda Energy, the Chuditch project, and drilling plans for 2025...

ICG Enterprise Trust’s key insights and strategies (LON:ICGT)

Learn more about ICG Enterprise Trust plc (LON:ICGT) in this exclusive interview with Hardman & Co's Analyst Mark Thomas. Discover key insights on their performance and strategies...

Ilika’s Graeme Purdy on fundraising and key milestones (LON:IKA)

Ilika plc CEO Graeme Purdy discusses proposed placing, trading update, and key milestones in exclusive interview. Details on proceeds and operational highlights...

NB Private Equity Partners 2023 performance and EBITDA margins (LON:NBPE)

Discover why NB Private Equity Partners (LON:NBPE) is making waves in the market with Hardman & Co's exclusive interview with DirectorsTalk...

Duke Capital’s unique hybrid capital solutions for SME growth and investor returns (LON:DUKE)

Learn about Duke Capital plc (LON:DUKE) and its unique hybrid capital solution for SMEs in UK, Europe, and North America in this exclusive interview summary...

itim Group CEO & CFO discuss Financial Success, Strategic Investments, and Future Outlook

Discover how itim Group plc (LON:ITIM) has increased revenues by 15% and EBITDA by 200%. Learn about their resilient business model and future strategies...

Cerillion CEO on Strong Interim Results, Strategic Growth, and Confidence in Future Prospects (LON:CER)

Cerillion plc CEO Louis Hall discusses interim results, product potential, and scaling up for growth in an exclusive interview with DirectorsTalk...

Zotefoams expands horizons with Shincell Global Alliance (LON:ZTF)

Zotefoams plc CFO Gary McGrath discusses the Shincell Global Alliance in an exclusive interview with DirectorsTalk. Find out what investors can expect in the coming months...

One Health Group plc CEO on Progress, Future Outlook, and NHS Contracts (AQSE:OHGR)

One Health Group plc CEO Adam Binns discusses their progress, future outlook, five-year NHS contracts, and the impact of political change in an exclusive interview...

Chesnara Plc results showcase Strong Economic Value Profit and Dividend Uplift (LON:CSN)

Learn about Chesnara plc's 2023 results and operational improvements in this exclusive interview with Hardman & Co's Financial Analyst Dr Brian Moretta...

City of London Investment Group Q3 update, FUM rises 5.5% (LON:CLIG)

City of London Investment Group plc (LON:CLIG) saw a positive quarter with $10.1 billion in Funds under Management. Find out more in this exclusive interview...

Avation’s Executive Chairman on the good working relationship with ATR, adding further growth (LON:AVAP)

Avation plc Executive Chairman Jeff Chatfield discusses AT2 72 engines, SAF certification, and more in an exclusive interview with DirectorsTalk. Learn about the company's growth sources and commitment to low CO2 transition...

Argent BioPharma MD on being a meaningful breakthrough drug discovery company (ASX:RGT)

Roby Zomer, CEO of Argent BioPharma Ltd, discusses the company's restructuring, product portfolio, and outlook in an exclusive interview with DirectorsTalk. Learn more about their focus on drug discovery and biopharma...
Search

Funds

Q & A

FTSE 100

Funds

Category: Q & A